HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells.

HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells.

Frontiers in pharmacology (2018-01-13)

Wen-Tsung Huang, Yu-Hsuan Tsai, Shang-Hung Chen, Ching-Wen Kuo, Yao-Lung Kuo, Kuo-Ting Lee, Wen-Chung Chen, Pei Chih Wu, Chun-Yu Chuang, Siao Muk Cheng, Chun-Hui Lin, Euphemia Yee Leung, Yung-Chieh Chang, Chun Hei Antonio Cheung

PMID29326587

摘要

Intrinsic or acquired resistance to hormone therapy is frequently reported in estrogen receptor positive (ER

材料

货号

品牌

产品描述

A2153

Sigma-Aldrich

牛血清白蛋白来源于牛血清, lyophilized powder, ≥96% (agarose gel electrophoresis)

C2978

Sigma-Aldrich

CelLytic^™ M, Cell Lysis Reagent, Suitable for Mammalian cell lysis and protein solubilization.

07-645

Sigma-Aldrich

抗Sp1抗体, Upstate^®, from rabbit

EHU002001

Sigma-Aldrich

MISSION^® esiRNA, targeting human HDAC2